Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$59.60 USD

59.60
22,361,140

+3.56 (6.35%)

Updated May 31, 2024 04:00 PM ET

Pre-Market: $59.52 -0.08 (-0.13%) 8:10 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 4% (239 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

CVS Health (CVS) Gets Final Approval to Close Aetna Deal

Both CVS Health (CVS) and Aetna are hopeful about this consolidation, which is aimed at revolutionizing consumer health care experience and substantial cost reduction.

4 Stocks to Buy as US Labor Market Reaches Full Potential

An overly tight labor market could push wages up further, increasing consumer optimism around spending.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $75.07, marking a -0.6% move from the previous day.

Near-Term Outlook for Health Maintenance Organization Industry

Retiring baby boomer population, new streams of revenues and consolidation paint a bright picture for the HMO industry.

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed at $80.34 in the latest trading session, marking a +0.64% move from the prior day.

CVS Health's (CVS) Q3 Earnings Top Estimate, Gross Margin Up

CVS Health's (CVS) year-over-year growth in the top line was driven by a strong Pharmacy Services segment, benefiting from the upside in the specialty services.

Ryan McQueeney headshot

Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR

Ryan McQueeney chats with Dave Bartosiak about the near-term outlook for stocks after the midterm elections and the earnings outlook for Turtle Beach ahead of its report. The host also recaps earnings results from CVS, Eli Lilly, and Regeneron.

Ryan McQueeney headshot

Stocks Gain Ahead of Midterm Results, But Where Are They Headed Next?

U.S. stocks opened modestly higher on Tuesday, as investors kept a watchful eye on the historically tense midterm elections. Here's what market strategists are saying will happen after the midterms.

September JOLTS Report In Spotlight

September JOLTS Report In Spotlight

Mark Vickery headshot

Playing the Waiting Game; Plus MedTech, Pharma in Q3 Earnings

We won't get the final numbers until later, so until then we're just playing the waiting game.

CVS Health (CVS) Q3 Earnings and Revenues Surpass Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 1.17% and 0.17%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Benjamin Rains headshot

What to Expect from CVS Health's Q3 Earnings

Let's see what to expect from CVS before the opening bell Tuesday.

Benjamin Rains headshot

Should You Buy CVS Stock Ahead of Q3 Earnings?

Let's see if investors should think about buying CVS stock ahead of its Q3 financial results.

Ryan McQueeney headshot

Upcoming Earnings Reports to Watch: CVS, QCOM, DIS

Stocks were down in morning trading Friday, putting major indexes on track to snap a three-day winning streak that followed a brutal month of selling. But will next week's earnings results get the rebound back on track? Let's take a closer look at a few of the earnings announcements due during the week of November 5!

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed the most recent trading day at $72.84, moving +0.61% from the previous trading session.

Will CVS Health's (CVS) PBM Strength Boost Q3 Earnings?

Despite a challenging pricing scenario, CVS Health (CVS) is currently gaining on high level of service and execution as well as a competitive pricing along with unique integrated model.

Aetna (AET) Q3 Earnings Beat Estimates, Membership Increases

Aetna (AET) earnings grow on revenue and membership gains.

CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed the most recent trading day at $70.67, moving +1.23% from the previous trading session.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed at $73.72 in the latest trading session, marking a +0.9% move from the prior day.

Benjamin Rains headshot

Walgreens Boots (WBA) Stock Looks Like A Cheap, Solid Buy Right Now

Shares of Walgreens Boots Alliance (WBA) jumped roughly 1.6% Monday as investors continue to dive in after it posted impressive fiscal fourth-quarter results late last week. Looking ahead, the pharmaceutical giant looks poised for strong growth and WBA stock seems like it might be worth buying right now.

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CVS Health (CVS) Stock Moves -0.72%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $78.92, marking a -0.72% move from the previous day.

Benjamin Rains headshot

Walgreens (WBA) Stock Sinks 1.7% Ahead of Q4 Earnings: What to Watch

Shares of Walgreens Boots Alliance (WBA) slipped 1.7% during regular trading hours Wednesday in a sign that investors might be a tad bit nervous about the pharmacy and cosmetic giant's Q4 earnings results Thursday.

The Zacks Analyst Blog Highlights: JPMorgan, American Express, FedEx, PepsiCo and CVS

The Zacks Analyst Blog Highlights: JPMorgan, American Express, FedEx, PepsiCo and CVS